Search

everythinglearnresearchcommunity

for

Search:↓

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Mesenchymal stem cell therapy shows promise for treating certain inflammatory skin diseases, but more research is needed.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

JAK inhibitors show promise for treating skin diseases effectively and safely.

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

A personalized treatment combining traditional and new therapies may improve hair loss outcomes in alopecia areata.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

JAK inhibitors show promise for treating Alopecia Areata, but more research is needed for better, accessible treatments.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

Adding a second method to PROTACs could improve cancer treatment.

Nanocarriers can improve skin treatments after cancer therapy by enhancing antioxidant delivery and effectiveness.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

New treatments for severe alopecia areata show promise but lack standard approval.

Plasmatherapy improves immune status in vitiligo patients, especially those with segmental vitiligo.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

UV radiation may cause DNA changes in skin, certain UVB therapy helps psoriasis, a new gene mutation is linked to mild piebaldism, different immune cells affect psoriasis, a drug promotes hair growth, and some cancer drugs could treat skin barrier issues.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Nanotechnology improves CRISPR-Cas9 delivery for cancer treatment, but challenges remain.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.